Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PTH vs PSCH overlap: 35% of top holdings shared

Bottom line

How much do PTH and PSCH overlap?

35% of their top holdings overlap by weight. 3 securities appear in both funds' top 25, making up 31.7% of PTH's assets and 34.1% of PSCH's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

PTHPSCH
Weight overlap (top 25)35%
Shared holdings3
Weight in shared holdings31.7%34.1%
Total positions5781
Expense ratio0.6%0.29%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings PTH and PSCH have in common

Holding% of PTH% of PSCHOverlap
Invesco Private Prime Fund20.79%21.48%20.79%
Invesco Private Government Fund6.84%8.27%6.84%
BrightSpring Health Services, Inc.4.03%4.35%4.03%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PTH

  1. Guardant Health, Inc. — 4.97%
  2. Roivant Sciences Ltd. — 4.95%
  3. Revolution Medicines, Inc. — 4.94%
  4. Axsome Therapeutics, Inc. — 4.12%
  5. Liquidia Corp. — 3.01%
  6. Erasca, Inc. — 2.94%
  7. Oruka Therapeutics, Inc. — 2.74%
  8. 10x Genomics, Inc. — 2.27%
  9. Relay Therapeutics, Inc. — 2.25%
  10. Tango Therapeutics Inc. — 2.16%
  11. Travere Therapeutics, Inc. — 2.16%
  12. Oscar Health, Inc. — 2.10%
  13. Illumina, Inc. — 2.08%
  14. agilon health, Inc. — 2.07%
  15. Axogen, Inc. — 2.06%

Only in PSCH

  1. Molina Healthcare, Inc. — 4.77%
  2. Krystal Biotech, Inc. — 4.25%
  3. Alkermes PLC — 3.71%
  4. Corcept Therapeutics Inc. — 3.47%
  5. Glaukos Corp. — 3.17%
  6. PTC Therapeutics, Inc. — 3.16%
  7. Protagonist Therapeutics, Inc. — 3.12%
  8. Teleflex Inc. — 3.03%
  9. TG Therapeutics, Inc. — 2.75%
  10. Ligand Pharmaceuticals Inc. — 2.43%
  11. Indivior Pharmaceuticals, Inc. — 2.40%
  12. RadNet, Inc. — 2.06%
  13. Merit Medical Systems, Inc. — 1.99%
  14. Veracyte, Inc. — 1.95%
  15. Catalyst Pharmaceuticals, Inc. — 1.92%

Asset mix

Asset typePTHPSCH
Stocks100.0%99.9%
Cash & short-term funds27.7%29.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryPTHPSCH
US116.1%125.2%
BM5.0%—
IE3.0%4.5%
VG1.5%—
NL1.5%—
JE0.6%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PTH and PSCH overlap?
About 35% by weight. 3 securities appear in both funds' top 25 holdings; they make up 31.7% of PTH's assets and 34.1% of PSCH's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PTH and PSCH have in common?
The largest shared holdings are Invesco Private Prime Fund, Invesco Private Government Fund, BrightSpring Health Services, Inc..
Should I own both PTH and PSCH?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PTH or PSCH?
PSCH is broader, with 81 positions versus 57 for PTH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.